183 related articles for article (PubMed ID: 38202807)
1. 5-Oxo-ETE/OXER1: A Link between Tumor Cells and Macrophages Leading to Regulation of Migration.
Kalyvianaki K; Salampasi EM; Katsoulieris EN; Boukla E; Vogiatzoglou AP; Notas G; Castanas E; Kampa M
Molecules; 2023 Dec; 29(1):. PubMed ID: 38202807
[TBL] [Abstract][Full Text] [Related]
2. The eosinophil chemoattractant 5-oxo-ETE and the OXE receptor.
Powell WS; Rokach J
Prog Lipid Res; 2013 Oct; 52(4):651-65. PubMed ID: 24056189
[TBL] [Abstract][Full Text] [Related]
3. Enhanced OXER1 expression is indispensable for human cancer cell migration.
Kalyvianaki K; Drosou I; Notas G; Castanas E; Kampa M
Biochem Biophys Res Commun; 2021 Dec; 584():95-100. PubMed ID: 34775286
[TBL] [Abstract][Full Text] [Related]
4. Mining the ZINC database of natural products for specific, testosterone-like, OXER1 antagonists.
Panagiotopoulos AA; Konstantinou E; Pirintsos SA; Castanas E; Kampa M
Steroids; 2023 Nov; 199():109309. PubMed ID: 37696380
[TBL] [Abstract][Full Text] [Related]
5. Structural requirements for activation of the 5-oxo-6E,8Z, 11Z,14Z-eicosatetraenoic acid (5-oxo-ETE) receptor: identification of a mead acid metabolite with potent agonist activity.
Patel P; Cossette C; Anumolu JR; Gravel S; Lesimple A; Mamer OA; Rokach J; Powell WS
J Pharmacol Exp Ther; 2008 May; 325(2):698-707. PubMed ID: 18292294
[TBL] [Abstract][Full Text] [Related]
6. Antagonizing effects of membrane-acting androgens on the eicosanoid receptor OXER1 in prostate cancer.
Kalyvianaki K; Gebhart V; Peroulis N; Panagiotopoulou C; Kiagiadaki F; Pediaditakis I; Aivaliotis M; Moustou E; Tzardi M; Notas G; Castanas E; Kampa M
Sci Rep; 2017 Mar; 7():44418. PubMed ID: 28290516
[TBL] [Abstract][Full Text] [Related]
7. Expression and characterization of a 5-oxo-6E,8Z,11Z,14Z-eicosatetraenoic acid receptor highly expressed on human eosinophils and neutrophils.
Jones CE; Holden S; Tenaillon L; Bhatia U; Seuwen K; Tranter P; Turner J; Kettle R; Bouhelal R; Charlton S; Nirmala NR; Jarai G; Finan P
Mol Pharmacol; 2003 Mar; 63(3):471-7. PubMed ID: 12606753
[TBL] [Abstract][Full Text] [Related]
8. New Antagonists of the Membrane Androgen Receptor OXER1 from the ZINC Natural Product Database.
Panagiotopoulos AA; Kalyvianaki K; Notas G; Pirintsos SA; Castanas E; Kampa M
ACS Omega; 2021 Nov; 6(44):29664-29674. PubMed ID: 34778638
[TBL] [Abstract][Full Text] [Related]
9. LTA(4)-derived 5-oxo-eicosatetraenoic acid: pH-dependent formation and interaction with the LTB(4) receptor of human polymorphonuclear leukocytes.
Falgueyret J; Riendeau D
Biochim Biophys Acta; 2000 Feb; 1484(1):51-8. PubMed ID: 10685030
[TBL] [Abstract][Full Text] [Related]
10. 5-Oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of human eosinophil migration.
Powell WS; Chung D; Gravel S
J Immunol; 1995 Apr; 154(8):4123-32. PubMed ID: 7706749
[TBL] [Abstract][Full Text] [Related]
11. Targeting the OXE receptor as a potential novel therapy for asthma.
Powell WS; Rokach J
Biochem Pharmacol; 2020 Sep; 179():113930. PubMed ID: 32240653
[TBL] [Abstract][Full Text] [Related]
12. A biased non-Gαi OXE-R antagonist demonstrates that Gαi protein subunit is not directly involved in neutrophil, eosinophil, and monocyte activation by 5-oxo-ETE.
Konya V; Blättermann S; Jandl K; Platzer W; Ottersbach PA; Marsche G; Gütschow M; Kostenis E; Heinemann A
J Immunol; 2014 May; 192(10):4774-82. PubMed ID: 24733850
[TBL] [Abstract][Full Text] [Related]
13. Enhanced formation of 5-oxo-6,8,11,14-eicosatetraenoic acid by cancer cells in response to oxidative stress, docosahexaenoic acid and neutrophil-derived 5-hydroxy-6,8,11,14-eicosatetraenoic acid.
Grant GE; Rubino S; Gravel S; Wang X; Patel P; Rokach J; Powell WS
Carcinogenesis; 2011 Jun; 32(6):822-8. PubMed ID: 21393477
[TBL] [Abstract][Full Text] [Related]
14. Membrane Androgen Receptors Unrelated to Nuclear Steroid Receptors.
Thomas P
Endocrinology; 2019 Apr; 160(4):772-781. PubMed ID: 30753403
[TBL] [Abstract][Full Text] [Related]
15. Metabolism and biologic effects of 5-oxoeicosanoids on human neutrophils.
Powell WS; MacLeod RJ; Gravel S; Gravelle F; Bhakar A
J Immunol; 1996 Jan; 156(1):336-42. PubMed ID: 8598482
[TBL] [Abstract][Full Text] [Related]
16. Membrane androgen receptors (OXER1, GPRC6A AND ZIP9) in prostate and breast cancer: A comparative study of their expression.
Kalyvianaki K; Panagiotopoulos AA; Malamos P; Moustou E; Tzardi M; Stathopoulos EN; Ioannidis GS; Marias K; Notas G; Theodoropoulos PA; Castanas E; Kampa M
Steroids; 2019 Feb; 142():100-108. PubMed ID: 30707908
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, molecular modelling studies and biological evaluation of new oxoeicosanoid receptor 1 agonists.
Stepniewski TM; Torrens-Fontanals M; Rodríguez-Espigares I; Giorgino T; Primdahl KG; Vik A; Stenstrøm Y; Selent J; Hansen TV
Bioorg Med Chem; 2018 Jul; 26(12):3580-3587. PubMed ID: 29866479
[TBL] [Abstract][Full Text] [Related]
18. TG1019/OXE, a Galpha(i/o)-protein-coupled receptor, mediates 5-oxo-eicosatetraenoic acid-induced chemotaxis.
Hosoi T; Sugikawa E; Chikada A; Koguchi Y; Ohnuki T
Biochem Biophys Res Commun; 2005 Sep; 334(4):987-95. PubMed ID: 16039985
[TBL] [Abstract][Full Text] [Related]
19. OXER1 mediates testosterone-induced calcium responses in prostate cancer cells.
Panagiotopoulos AA; Kalyvianaki K; Serifoglou B; Konstantinou E; Notas G; Castanas E; Kampa M
Mol Cell Endocrinol; 2022 Jan; 539():111487. PubMed ID: 34634385
[TBL] [Abstract][Full Text] [Related]
20. 15-oxo-Eicosatetraenoic acid, a metabolite of macrophage 15-hydroxyprostaglandin dehydrogenase that inhibits endothelial cell proliferation.
Wei C; Zhu P; Shah SJ; Blair IA
Mol Pharmacol; 2009 Sep; 76(3):516-25. PubMed ID: 19535459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
